Similar articles

• Ocular chloramphenicol and aplastic anemia.

  Fraunfelder FT, Bagby GC Jr. Fraunfelder FT, et al. N Engl J Med. 1983 Jun 23;308(25):1536. doi: 10.1056/NEJM198306233082513. N Engl J Med. 1983. PMID: 6855828 No abstract available.
• [Chloramphenicol in ophthalmic instillation and risk of generalized sensitization].

  Verin P, Sekkat A, Morax S. Verin P, et al. Bull Soc Ophtalmol Fr. 1972 Mar;72(3):365-70. Bull Soc Ophtalmol Fr. 1972. PMID: 4643424 French. No abstract available.
• Aplastic anemia following topical administration of ophthalmic chloramphenicol: report of a case and review of the literature.

  Issaragrisil S, Piankijagum A. Issaragrisil S, et al. J Med Assoc Thai. 1985 Jun;68(6):309-12. J Med Assoc Thai. 1985. PMID: 4056637 No abstract available.
• Topical chloramphenicol for eye infections.

  Lam RF, Lai JS, Ng JS, Rao SK, Law RW, Lam DS. Lam RF, et al. Hong Kong Med J. 2002 Feb;8(1):44-7. Hong Kong Med J. 2002. PMID: 11861993 Review.
• It is time to stop using topical chloramphenicol.

  Smith JR, Wesselingh S, Coster DJ. Smith JR, et al. Aust N Z J Ophthalmol. 1997 Feb;25(1):83-8. doi: 10.1111/j.1442-9071.1997.tb01283.x. Aust N Z J Ophthalmol. 1997. PMID: 9107404 Review. No abstract available.